Advertisement

Long-Term Safety and Efficacy of Staged Percutaneous Coronary Intervention for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease

      The relative benefit of staged percutaneous coronary intervention (PCI) versus culprit-only PCI in patients with ST-segment elevation myocardial infarction and multivessel coronary disease remains disputable. Therefore, we conducted this study to compare the long-term outcomes of staged complete revascularization and culprit-only PCI in this population. A total of 1,205 patients were treated with staged PCI (n = 576) or culprit-only PCI (n = 629) from January 2006 to December 2015 in our center. After propensity-score matching, 415 pairs of patients were identified, and postmatching absolute standardized differences were <10% for all covariates. The primary endpoint was major adverse cardiac and cerebrovascular event (MACCE), defined as a composite of all-cause death, myocardial infarction (MI), stroke, or unplanned revascularization. The mean follow-up duration was 5 years. Overall, staged complete revascularization was associated with lower risks of MACCE, MI, unplanned revascularization, and a composite of cardiac death, MI or stroke compared with culprit-only PCI in both overall population and propensity-matched cohorts. In Cox proportional hazards regression analysis, the strategy of staged PCI was consistently a significant predictor of lower incidences of MACCE, MI, unplanned revascularization and a composite of cardiac death, MI, or stroke. However, there was no difference in the risks of MACCE, MI and unplanned revascularization between the 2 approaches for diabetic patients. In conclusion, among patients with ST-segment elevation myocardial infarction and multivessel disease who underwent primary PCI, an approach of staged complete revascularization is superior to culprit-only PCI at 5-year follow-up. Nevertheless, the advantage of staged PCI is attenuated in diabetic patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sorajja P.
        • Gersh B.J.
        • Cox D.A.
        • McLaughlin M.G.
        • Zimetbaum P.
        • Costantini C.
        • Stuckey T.
        • Tcheng J.E.
        • Mehran R.
        • Lansky A.J.
        • Grines C.L.
        • Stone G.W.
        Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
        Eur Heart J. 2007; 28: 1709-1716
        • O'Gara P.T.
        • Kushner F.G.
        • Ascheim D.D.
        • Casey Jr., D.E.
        • Chung M.K.
        • de Lemos J.A.
        • Ettinger S.M.
        • Fang J.C.
        • Fesmire F.M.
        • Franklin B.A.
        • Granger C.B.
        • Krumholz H.M.
        • Linderbaum J.A.
        • Morrow D.A.
        • Newby L.K.
        • Ornato J.P.
        • Ou N.
        • Radford M.J.
        • Tamis-Holland J.E.
        • Tommaso C.L.
        • Tracy C.M.
        • Woo Y.J.
        • Zhao D.X.
        • Anderson J.L.
        • Jacobs A.K.
        • Halperin J.L.
        • Albert N.M.
        • Brindis R.G.
        • Creager M.A.
        • DeMets D.
        • Guyton R.A.
        • Hochman J.S.
        • Kovacs R.J.
        • Kushner F.G.
        • Ohman E.M.
        • Stevenson W.G.
        • Yancy C.W.
        2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
        J Am Coll Cardiol. 2013; 61: e78-e140
        • Park D.W.
        • Clare R.M.
        • Schulte P.J.
        • Pieper K.S.
        • Shaw L.K.
        • Califf R.M.
        • Ohman E.M.
        • Van de Werf F.
        • Hirji S.
        • Harrington R.A.
        • Armstrong P.W.
        • Granger C.B.
        • Jeong M.H.
        • Patel M.R.
        Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction.
        JAMA. 2014; 312: 2019-2027
        • Ibanez B.
        • James S.
        • Agewall S.
        • Antunes M.J.
        • Bucciarelli-Ducci C.
        • Bueno H.
        • Caforio A.L.P.
        • Crea F.
        • Goudevenos J.A.
        • Halvorsen S.
        • Hindricks G.
        • Kastrati A.
        • Lenzen M.J.
        • Prescott E.
        • Roffi M.
        • Valgimigli M.
        • Varenhorst C.
        • Vranckx P.
        • Widimský P.
        • ESC Scientific Document Group
        2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).
        Eur Heart J. 2018; 39: 119-177
        • Dambrink J.H.
        • Debrauwere J.P.
        • van 't Hof A.W.
        • Ottervanger J.P.
        • Gosselink A.T.
        • Hoorntje J.C.
        • de Boer M.J.
        • Suryapranata H.
        Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines.
        EuroIntervention. 2010; 5: 968-975
        • Ghani A.
        • Dambrink J.H.
        • van 't Hof A.W.
        • Ottervanger J.P.
        • Gosselink A.T.
        • Hoorntje J.C.
        Treatment of nonculprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial.
        Neth Heart J. 2012; 20: 347-353
        • Cavender M.A.
        • Milford-Beland S.
        • Roe M.T.
        • Peterson E.D.
        • Weintraub W.S.
        • Rao S.V.
        Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry).
        Am J Cardiol. 2009; 104: 507-513
        • Dziewierz A.
        • Siudak Z.
        • Rakowski T.
        • Zasada W.
        • Dubiel J.S.
        • Dudek D.
        Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER Registry).
        Am J Cardiol. 2010; 106: 342-347
        • Hannan E.L.
        • Samadashvili Z.
        • Walford G.
        • H. Jr, D.R.
        • Jacobs A.K.
        • Stamato N.J.
        • Venditti F.J.
        • Sharma S.
        • King 3rd, S.B.
        Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.
        JACC Cardiovasc Interv. 2010; 3: 22-31
        • Kornowski R.
        • Mehran R.
        • Dangas G.
        • Nikolsky E.
        • Assali A.
        • Claessen B.E.
        • Gersh B.J.
        • Wong S.C.
        • Witzenbichler B.
        • Guagliumi G.
        • Dudek D.
        • Fahy M.
        • Lansky A.J.
        • Stone G.W.
        • HORIZONS-AMI Trial Investigators
        Prognostic impact of staged versus “one-time” multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
        J Am Coll Cardiol. 2011; 58: 704-711
        • Wald D.S.
        • Morris J.K.
        • Wald N.J.
        • Chase A.J.
        • Edwards R.J.
        • Hughes L.O.
        • Berry C.
        • Oldroyd K.G.
        • PRAMI Investigators
        Randomized trial of preventive angioplasty in myocardial infarction.
        N Engl J Med. 2013; 369: 1115-1123
        • Gershlick A.H.
        • Khan J.N.
        • Kelly D.J.
        • Greenwood J.P.
        • Sasikaran T.
        • Curzen N.
        • Blackman D.J.
        • Dalby M.
        • Fairbrother K.L.
        • Banya W.
        • Wang D.
        • Flather M.
        • Hetherington S.L.
        • Kelion A.D.
        • Talwar S.
        • Gunning M.
        • Hall R.
        • Swanton H.
        • McCann G.P.
        Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.
        J Am Coll Cardiol. 2015; 65: 963-972
        • Engstrøm T.
        • Kelbæk H.
        • Helqvist S.
        • Høfsten D.E.
        • Kløvgaard L.
        • Holmvang L.
        • Jørgensen E.
        • Pedersen F.
        • Saunamäki K.
        • Clemmensen P.
        • De Backer O.
        • Ravkilde J.
        • Tilsted H.H.
        • Villadsen A.B.
        • Aarøe J.
        • Jensen S.E.
        • Raungaard B.
        • Køber L.
        • DANAMI-3—PRIMULTI Investigators
        Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial.
        Lancet. 2015; 386: 665-671
        • Smits P.C.
        • Abdel-Wahab M.
        • Neumann F.J.
        • Boxma-de Klerk B.M.
        • Lunde K.
        • Schotborgh C.E.
        • Piroth Z.
        • Horak D.
        • Wlodarczak A.
        • Ong P.J.
        • Hambrecht R.
        • Angerås O.
        • Richardt G.
        • Omerovic E.
        • Compare-Acute Investigators
        Fractional flow reserve-guided multivessel angioplasty in myocardial infarction.
        N Engl J Med. 2017; 376: 1234-1244
        • Levine G.N.
        • Bates E.R.
        • Blankenship J.C.
        • Bailey S.R.
        • Bittl J.A.
        • Cercek B.
        • Chambers C.E.
        • Ellis S.G.
        • Guyton R.A.
        • Hollenberg S.M.
        • Khot U.N.
        • Lange R.A.
        • Mauri L.
        • Mehran R.
        • Moussa I.D.
        • Mukherjee D.
        • Ting H.H.
        • O'Gara P.T.
        • Kushner F.G.
        • Ascheim D.D.
        • Brindis R.G.
        • Casey Jr., D.E.
        • Chung M.K.
        • de Lemos J.A.
        • Diercks D.B.
        • Fang J.C.
        • Franklin B.A.
        • Granger C.B.
        • Krumholz H.M.
        • Linderbaum J.A.
        • Morrow D.A.
        • Newby L.K.
        • Ornato J.P.
        • Ou N.
        • Radford M.J.
        • Tamis-Holland J.E.
        • Tommaso C.L.
        • Tracy C.M.
        • Woo Y.J.
        • Zhao D.X.
        2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with st-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of st-elevation myocardial infarction.
        J Am Coll Cardiol. 2016; 67: 1235-1250
        • Thygesen K.
        • Alpert J.S.
        • Jaffe A.S.
        • Chaitman B.R.
        • Bax J.J.
        • Morrow D.A.
        • White H.D.
        • ESC Scientific Document Group
        Fourth universal definition of myocardial infarction (2018).
        Eur Heart J. 2019; 40: 237-269
        • Barber M.
        • Stott D.J.
        • Langhorne P.
        An internationally agreed definition of progressing stroke.
        Cerebrovasc Dis. 2004; 18 (author reply 256-257): 255-256
        • Ghali W.A.
        • Quan H.
        • Brant R.
        • van Melle G.
        • Norris C.M.
        • Faris P.D.
        • Galbraith P.D.
        • Knudtson M.L.
        • APPROACH (Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease) Investigators
        Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models.
        JAMA. 2001; 286: 1494-1497
        • Pundziute G.
        • Schuijf J.D.
        • Jukema J.W.
        • Decramer I.
        • Sarno G.
        • Vanhoenacker P.K.
        • Boersma E.
        • Reiber J.H.
        • Schalij M.J.
        • Wijns W.
        • Bax J.J.
        Evaluation of plaque characteristics in acute coronary syndromes: noninvasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis.
        Eur Heart J. 2008; 29: 2373-2381
        • Lu D.Y.
        • Zhong M.
        • Feldman D.N.
        Complete versus culprit-only revascularization in STEMI: a contemporary review.
        Curr Treat Options Cardiovasc Med. 2018; 20: 41
        • Toyota T.
        • Shiomi H.
        • Taniguchi T.
        • Morimoto T.
        • Furukawa Y.
        • Nakagawa Y.
        • Horie M.
        • Kimura T.
        • CREDO-Kyoto AMI Registry Investigators
        Culprit vessel-only vs. staged multivessel percutaneous coronary intervention strategies in patients with multivessel coronary artery disease undergoing primary percutaneous coronary intervention for st-segment elevation myocardial infarction.
        Circ J. 2016; 80: 371-378
        • West N.E.
        • Ruygrok P.N.
        • Disco C.M.
        • Webster M.W.
        • Lindeboom W.K.
        • O'Neill W.W.
        • Mercado N.F.
        • Serruys P.W.
        Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients.
        Circulation. 2004; 109: 867-873
        • Alfonso F.
        • Rivero F.
        Coronary revascularization in diabetic patients with chronic kidney disease.
        Eur Heart J. 2016; 37: 3448-3451